The myopathic protein myotilin in developing mouse and in muscle function (original) (raw)
Related papers
The expression of myosin genes in developing skeletal muscle in the mouse embryo
The Journal of Cell Biology, 1990
Using in situ hybridization, we have investigated the temporal sequence of myosin gene expression in the developing skeletal muscle masses of mouse embryos. The probes used were isoform-specific, 35S-labeled antisense cRNAs to the known sarcomeric myosin heavy chain and myosin alkali light chain gene transcripts. Results showed that both cardiac and skeletal myosin heavy chain and myosin light chain mRNAs were first detected between 9 and 10 d post coitum (p.c.) in the myotomes of the most rostral somites. Myosin transcripts appeared in more caudal somites at later stages in a developmental gradient. The earliest myosin heavy chain transcripts detected code for the embryonic skeletal (MHCemb) and beta-cardiac (MHC beta) isoforms. Perinatal myosin heavy chain (MHCpn) transcripts begin to accumulate at 10.5 d p.c., which is much earlier than previously reported. At this stage, MHCemb is the major MHC transcript. By 12.5 d p.c., MHCpn and MHCemb mRNAs are present to an equal extent, an...
Characterization of mouse myotilin and its promoter
Biochemical and Biophysical Research Communications, 2005
Myotilin is a sarcomeric protein mutated in two forms of muscle disease, limb-girdle muscular dystrophy type 1A and myofibrillar myopathy. Myotilin is expressed late during human myofibrillogenesis and localizes to Z-discs in mature sarcomere. It interacts with a-actinin, actin, and filamin C, and has strong F-actin-bundling activity. These features suggest an important role for myotilin in sarcomere organization. In our effort towards the construction of a genetic model for myotilin-related muscle disorders, we have cloned mouse myotilin, including its promoter region, and studied the expression in various tissues. Mouse myotilin is 90% identical with the human orthologue. Northern blot analysis revealed strong mRNA transcripts in skeletal and cardiac muscle, and weak expression in liver and lung tissue. Western blot and RT-PCR analysis showed the presence of one major product in mouse tissues. Analysis of the 5 0 -flanking region revealed a number of putative regulatory elements that drive expression in differentiating myoblasts. Finally, endogenous myotilin is induced at later stages of Z-disc assembly in C 2 C 12 cells indicating conservation between mouse and human promoter region.
Expression of myosin heavy chain isoforms in the postnatal mouse masseter muscle
Okajimas Folia Anatomica Japonica, 2009
We investigated the properties of the masseter muscle in mice from five to seven weeks of age. Myosin heavy chain (MyHC) isoforms were measured in the masseter muscle. The three types of muscle fibers (Type I, strong reaction; Type IIA, intermediate reaction; and Type IIB, weak reaction) were all present in the masseter muscle in five-weeks-old mice and seven-weeks-old mice, the three types could be clearly distinguished by their enzyme activity. The percentage of Type IIB fibers (above 50%) was the highest among all fiber types both 5-and 7-weeks-old mice. The mRNA levels for myosin slow and myosin IIb increased significantly between 5 and 7 weeks. These observations suggest that muscle fiber size, muscle fiber types and mRNA levels of the MyHC isoforms all contribute to the diminished functional adaptability of enzyme activity in the masseter muscle.
Development (Cambridge, England), 1991
We have analysed by in situ hybridization the expression of myf-5, the murine homologue of the human myogenic regulatory sequence myf5, during embryogenesis in the mouse. myf-5 sequences were first detected in the earliest somites (from about 8 days p.c.) in the dermomyotome, before formation of the dermatome, myotome and sclerotome. The dermomyotome is classically considered to give rise to the precursor muscle cells of body and limb skeletal muscle. myf-5-positive cells were also detected early in the visceral arches and limb buds. In this case, as in somites, myf-5 expression precedes that of the two related myogenic regulatory sequences, myogenin and MyoD1, and indeed any other skeletal muscle marker examined to date. myf-5 is not detected at any stage in developing cardiac muscle. From 11.5 days p.c., the level of myf-5 transcripts begins to decrease to become undetectable (by in situ hybridization) from 14 days p.c. Both the appearance and disappearance of myf-5 follow the ant...
Development, 1993
A unique pattern of expression of the four muscle regulatory factor (MRF) proteins was found to distinguish early somitic from embryonic, fetal and newborn limb myogenic cells in vitro. Expression of the myosin heavy chain (MHC), MyoD, myogenin, Myf-5, and MRF4 proteins was examined by immunocytochemistry in cultures of four distinct types of mouse myogenic cells: somitic (E8.5), embryonic (E11.5), fetal (E16.5) and newborn limb. In embryonic, fetal and newborn cultures, the MRF proteins were expressed in generally similar patterns: MyoD was the first MRF expressed; MyoD and myogenin were expressed by more cells than Myf-5 or MRF4; and each of the four MRFs was found both in cells that expressed MHC and in cells that did not express MHC. In cultures of somitic cells, in contrast, Myf-5 was expressed first and by more cells than MyoD or myogenin; MRF4 was not detected; and the MRFs were never found to be coexpressed with MHC in the same cell. Thus, some somitic cells had the unexpect...
Differentiation, 1994
Cells of the embryonic mesenchymal cell line C3HlOT1/2 have revealed the potential that the four regulatory factors belonging to the MyoD family have to activate myogenesis. In the present study we have further investigated the myogenic phenotype of C3H10T1/2 cells stably transfected with either Myf5, MyoD, myogenin or MRF4 cDNAs. We have studied the influence of each transfected cDNA on expression of the four endogenous muscle regulatory genes and on the ability of these embryonic myogenic derivatives to express adult muscle genes. No trace of endogenous transcripts distinct from the exogenous one was found in any of the four converted populations at the myoblast stage. This indicates that cross-activation within the MyoD family does not occur at the myoblast stage in these cells. Similarly, evidence was obtained that auto-or cross-activation of the MyfS gene occurs neither at the myoblast stage nor at the myotube stage and that no autoactivation of the MRF4 gene occurs. Our results together with previous observations indicate that in C3H 10T1/2 myogenic derivatives: (1) Autoactivation at the myoblast stage is restricted to MyoD (2) Expression from each cDNA alone is sufficient to establish and maintain the myoblast phenotype (3) The endogenous MyfS gene is not mobilized. We have also observed that endogenous transcripts for MyoD and myogenin begin to accumulate at the onset of differentiation in the four myogenic derivatives, whereas accumulation of endogenous MRF4 transcripts starts after myotubes have formed and occurs at a much lower level (100-to 500-fold lower) than in differentiated cultures of myosatellite cells. However, neither this low level of MRF4 transcripts nor higher levels from the transfected MRF4 cDNA affected (prevented or stimulated) the accumulation of dystrophin transcripts or of adult muscle-gene transcripts (e.g., myosin heavy chain IIB, acetylcholine receptor &-subunit and M form of aldolase A), which occurred at similar levels in the four myogenic derivatives: Thus, despite the fact that MRF4 gene ex
A developmentally regulated disappearance of slow myosin in fast-type muscles of the mouse
FEBS Letters, 1984
Histochemistry and immunocytochemistry using an antibody to adult rat slow-type myosin demonstrated that about 10% of the fibers in the mouse extensor digitorum longus and semimembranosus muscles contain slow myosin during the first month after birth. In adult animals, these muscles have only t&0.8% slow myosin-containing fibers. These results demonstrate a developmentally linked disappearance of an adult-type myosin, and show that the adult phenotype of muscle fibers is not necessarily determined before birth as previously suggested.
Tertiary myotubes in postnatal growing pig muscle detected by their myosin isoform composition
Journal of animal science, 1992
The postnatal development of skeletal muscles was studied in growing pigs from 8 to 210 d of age. Indirect immunoperoxidase staining of frozen sections of porcine semimembranosus muscle and longissimus muscle revealed a distinct population of small fibers (tertiary myotubes) that were stained specifically by an antibody (anti-NE) selective for the developmental (embryonic and neonatal) isoforms of muscle myosin. At 8 d of age the other larger fibers were already anti-NE negative and differentiated into Types I and II. A gradual decrease in the number of anti-NE positive fibers together with a gradual increase in area of the remaining positive fibers was observed throughout the pigs' growth. These results may indicate that hyperplastic growth does not cease at birth. Possible mechanisms to explain the origin of these tertiary myotubes containing developmental isoforms of myosin are suggested.